EAM Investors’s Protalix BioTherapeutics PLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-165,631
Closed -$331K 359
2023
Q2
$331K Buy
+165,631
New +$331K 0.06% 256